Rahmi Aslan et al. 2023. Biologic Therapy Carries a Very Low Risk of Reactivation in Hepatitis B Surface Antigen-Negative Phase of Hepatitis B. Turkish Journal of Gastroenterology. 34, 2 (Feb. 2023), 156–160.